Last April NOTOCORD® signed a distribution agreement for software products and services with the company Bio-Dot Scientific in India.
An emerging market
The Indian pharmaceutical industry has been expanding steadily over the 5 years with an impressive annual growth rate above 15% making it one of the top five pharmaceutical emerging markets.
Foreign companies are increasing their operations in India which has become one of the most favoured destinations for collaborative Research & Development bioinformatics and clinical research.
By complying to the internal standards such as Good Laboratory Practices (GLP), India's pharmaceutical industry is becoming a major player in outsourced clinical research as well as contract manufacturing and research.
As a leading provider of data acquisition, analysis and reporting solutions, we are very interested in participating to the innovative and economic driving forces of the Indian pharmaceutical companies.
Discover Bio-Dot Scientific
To increase our presence on the Indian market and provide software to Contract Research Organizations (CROs) and new pharmaceutical companies, we developed a partnership with Bio-Dot Scientific, a distributor based in New-Delhi.
|Bio-Dot Scientific was founded in 2002 with skills in physiology, neuroscience, pharmacology, bio-medical engineering etc. Their fields of interest includes physiological recordings, isolated organ experiments, biomedical functions, electrophysiological and other nervous recordings.|
This new partner joins our network in Asia which now counts 6 distributors of NOTOCORD® software products, covering the People's Republic of China, Taiwan, Japan, South Korea and last but not least India.